183 related articles for article (PubMed ID: 35151875)
21. Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies.
Mendes SG; Combo SI; Allain T; Domingues S; Buret AG; Da Silva GJ
Eur J Clin Microbiol Infect Dis; 2023 Dec; 42(12):1405-1423. PubMed ID: 37897520
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Acinetobacter baumannii biofilm formation.
Gaddy JA; Actis LA
Future Microbiol; 2009 Apr; 4(3):273-8. PubMed ID: 19327114
[TBL] [Abstract][Full Text] [Related]
23. Understanding the biofilm development of Acinetobacter baumannii and novel strategies to combat infection.
Naseef Pathoor N; Viswanathan A; Wadhwa G; Ganesh PS
APMIS; 2024 May; 132(5):317-335. PubMed ID: 38444124
[TBL] [Abstract][Full Text] [Related]
24. Acinetobacter baumannii virulence is enhanced in Galleria mellonella following biofilm adaptation.
Wand ME; Bock LJ; Turton JF; Nugent PG; Sutton JM
J Med Microbiol; 2012 Apr; 61(Pt 4):470-477. PubMed ID: 22194338
[TBL] [Abstract][Full Text] [Related]
25. Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China.
Li J; Yu T; Luo Y; Peng JY; Li YJ; Tao XY; Hu YM; Wang HC; Zou MX
BMC Microbiol; 2020 Sep; 20(1):281. PubMed ID: 32928115
[TBL] [Abstract][Full Text] [Related]
26. Detection of quorum sensing signal molecules and identification of an autoinducer synthase gene among biofilm forming clinical isolates of Acinetobacter spp.
Anbazhagan D; Mansor M; Yan GO; Md Yusof MY; Hassan H; Sekaran SD
PLoS One; 2012; 7(7):e36696. PubMed ID: 22815678
[TBL] [Abstract][Full Text] [Related]
27. Disruption of biofilm formation by the human pathogen Acinetobacter baumannii using engineered quorum-quenching lactonases.
Chow JY; Yang Y; Tay SB; Chua KL; Yew WS
Antimicrob Agents Chemother; 2014; 58(3):1802-5. PubMed ID: 24379199
[TBL] [Abstract][Full Text] [Related]
28. Correlation of biofilm formation and antibiotic resistance among clinical and soil isolates of Acinetobacter baumannii in Iraq.
Hassan PA; Khider AK
Acta Microbiol Immunol Hung; 2020 Oct; 67(3):161-170. PubMed ID: 31833386
[TBL] [Abstract][Full Text] [Related]
29. Multiple Quorum Quenching Enzymes Are Active in the Nosocomial Pathogen
Mayer C; Muras A; Romero M; López M; Tomás M; Otero A
Front Cell Infect Microbiol; 2018; 8():310. PubMed ID: 30271754
[No Abstract] [Full Text] [Related]
30. A Novel Quorum-Quenching
Kusada H; Tamaki H; Kamagata Y; Hanada S; Kimura N
Appl Environ Microbiol; 2017 Jul; 83(13):. PubMed ID: 28455333
[No Abstract] [Full Text] [Related]
31. Evaluation of type II Toxin-Antitoxin Systems, Antibiotic Resistance Profiles, and Biofilm Quorum Sensing Genes in Acinetobacter Baumannii Isolates in Iraq.
Al Marjania MF; Kouhsari E; Ali FS; Authman SH
Infect Disord Drug Targets; 2021; 21(2):180-186. PubMed ID: 32484105
[TBL] [Abstract][Full Text] [Related]
32. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.
Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H
Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218
[TBL] [Abstract][Full Text] [Related]
33. Quorum-quenching potential of recombinant PvdQ-engineered bacteria for biofilm formation.
Li J; Li Z; Xie J; Xia Y; Gong W; Tian J; Zhang K; Yu E; Wang G
Int Microbiol; 2023 Aug; 26(3):639-650. PubMed ID: 36773196
[TBL] [Abstract][Full Text] [Related]
34. The Cell-Cell Communication Signal Indole Controls the Physiology and Interspecies Communication of Acinetobacter baumannii.
Cui B; Chen X; Guo Q; Song S; Wang M; Liu J; Deng Y
Microbiol Spectr; 2022 Aug; 10(4):e0102722. PubMed ID: 35862954
[TBL] [Abstract][Full Text] [Related]
35. An extensive computational study to identify potential inhibitors of Acyl-homoserine-lactone synthase from Acinetobacter baumannii (strain AYE).
Jha RK; Jabeer Khan R; Singh E; Kumar A; Jain M; Muthukumaran J; Singh AK
J Mol Graph Model; 2022 Jul; 114():108168. PubMed ID: 35339024
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the Different Stages of Biofilm Formation and Antibiotic Susceptibility in a Clinical
Da Cunda P; Iribarnegaray V; Papa-Ezdra R; Bado I; González MJ; Zunino P; Vignoli R; Scavone P
Microb Drug Resist; 2020 Jun; 26(6):569-575. PubMed ID: 31895639
[No Abstract] [Full Text] [Related]
37. A comprehensive profiling of quorum quenching by bacterial pigments identifies quorum sensing inhibition and antibiofilm action of prodigiosin against Acinetobacter baumannii.
Acharya K; Borborah S; Chatterjee A; Ghosh M; Bhattacharya A
Arch Microbiol; 2023 Oct; 205(12):364. PubMed ID: 37906317
[TBL] [Abstract][Full Text] [Related]
38. Enhancing pili assembly and biofilm formation in Acinetobacter baumannii ATCC19606 using non-native acyl-homoserine lactones.
Luo LM; Wu LJ; Xiao YL; Zhao D; Chen ZX; Kang M; Zhang Q; Xie Y
BMC Microbiol; 2015 Mar; 15():62. PubMed ID: 25888221
[TBL] [Abstract][Full Text] [Related]
39. Quorum Sensing as a Target for Controlling Surface Associated Motility and Biofilm Formation in
Mayer C; Muras A; Parga A; Romero M; Rumbo-Feal S; Poza M; Ramos-Vivas J; Otero A
Front Microbiol; 2020; 11():565548. PubMed ID: 33101239
[TBL] [Abstract][Full Text] [Related]
40. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.
Peleg AY; Jara S; Monga D; Eliopoulos GM; Moellering RC; Mylonakis E
Antimicrob Agents Chemother; 2009 Jun; 53(6):2605-9. PubMed ID: 19332683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
